Q-omics provides the consensus-scored RNU6-626P profile across patient tissues and cancer cell-line models. RNU6-626P expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RNU6-626P RNA expression shows 7,650 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight KIRC, and ESCA as cancer lineages where RNU6-626P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.